Biostage, Inc. Common Stock
BSTG
BSTG was delisted on the 5th of October, 2017.
27 hedge funds and large institutions have $1.55M invested in Biostage, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
80% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 5
4% more funds holding
Funds holding: 26 → 27 (+1)
30% less capital invested
Capital invested by funds: $2.23M → $1.55M (-$674K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$42.7K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$36.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$27.7K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$20.5K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$15.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSP
Tappan Street Partners
Chicago,
Illinois
|
-$284K |
| 2 |
WIC
Woodmont Investment Counsel
Nashville,
Tennessee
|
-$110K |
| 3 |
Renaissance Technologies
New York
|
-$16.1K |
| 4 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$12K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8.49K |
BSTG Hedge Fund Activity: Q4 2016 in Review
27 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Biostage, Inc. Common Stock (BSTG) for Q4 2016, worth a combined $1.55M — down 30% from $2.23M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BSTG positions and 2 closed out — a net gain of 2 holders — while 9 added to existing stakes and 5 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $42.7K. The largest seller was Tappan Street Partners, exiting entirely with an estimated $284K sold.
- 27 institutional investors held Biostage, Inc. Common Stock (BSTG) as of Q4 2016, up from 26 in Q3 2016.
- Funds reported $1.55M of Biostage, Inc. Common Stock stock for Q4 2016, down 30% quarter-over-quarter.
- 4 funds opened new Biostage, Inc. Common Stock positions in Q4 2016 and 2 closed out, a net change of +2 holders.
- The largest Biostage, Inc. Common Stock buyer in Q4 2016 was Susquehanna International Group, an estimated $42.7K added.
- The largest Biostage, Inc. Common Stock seller in Q4 2016 was Tappan Street Partners, an estimated $284K sold.
Based on aggregated 13F filings for Q4 2016.